home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

A Rogue Neighbourhood

 
  May, 1 2008 8:55
your information resource in human molecular genetics
 
     

Gene expression changes in the tissue microenvironment in which a tumour arises can be used to predict outcome in patients with breast cancer, suggests a report online in Nature Medicine.

Analysis of the genes expressed in cancer has provided important information that can help predict the aggressiveness of tumours and their likely response to therapy. Morag Park and colleagues show that the tumour connective tissue or 'stroma' also undergoes changes in gene expression that can help inform disease outcome. By analyzing the tissue surrounding breast tumours, they identify a gene signature that classifies tumours according to clinical outcomes, independent of other prognostic factors.

In addition to providing a new diagnostic tool for breast cancer, these findings highlight the emerging role of tumour stroma in cancer progression.

Author contact:

Morag Park (McGill University, Montreal, Quebec, Canada)
E-mail: morag.park@mcgill.ca

Abstract available online.

(C) Nature Medicine press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.